- Poster presentation
- Open Access
Ex vivo conditioning with IL-12 decreases T cell sensitivity to intratumoral INF-γ-induced apoptosis following adoptive transfer
© Diaz-Montero et al. 2015
Published: 4 November 2015
In order to induce significant tumor regression T cells must effectively recognize and kill target cells. Secretion of IFN-γ is considered a key effector function of activated CD8+ T cells via induction of apoptosis. Thus programming T cells to secrete high levels of IFN-γ after adoptive transfer could represent a therapeutically effective anti-cancer intervention.
We previously demonstrated that naïve CD8+ T cells exposed to IL-12 during antigenic priming (PmelAg+12) provided superior anti-tumor activity after transfer when compared to cells activated in the presence of antigen alone (PmelAg). In this setting, tumor regression was associated with sustained levels of intra-tumoral IFN-γ. Expression analysis using total tumor RNA showed elevated expression of IFN-γ responsive genes such as IP-10, MCP-1, MIG, and MIP-1α. Even without IL-12 stimulation during ex vivo antigenic priming, Pmel cells were able to initially reach the tumor and secrete high levels of IFN-γ. However, by day 7 after adoptive transfer tumors in mice that received PmelAg were significantly larger than those in mice injected with PmelAg+12. Failure to maintain intra-tumoral levels of IFN-γ was associated with a decrease in the frequency of tumor infiltrating PmelAg. We hypothesized that high levels of IFN-γ had a detrimental effect on PmelAg, via induction of apoptosis. IFN-γ is a multifunctional cytokine that induces a variety of contrasting cell responses such as proliferation or cell death. The cellular response to an IFN-γ stimulus depends on the specific receptor being activated, with IFN-γR1 inducing proliferation and IFN-γR2 inducing apoptosis.
We tested the hypothesis that the ability of T cells to survive in vivo after adoptive transfer was dependent on their susceptibility to IFN-γ-induced apoptosis. Real time PCR revealed that the expression levels of IFN-γR1 and IFN-γR2 immediately following antigen or antigen+ IL-12 priming were similar, though by 4d post adoptive transfer the tumor-infiltrating Pmel cells stimulated with antigen alone had 10 fold higher levels of IFN-γR2 than tumor associated PmelAg+IL-12.
These results suggest that the enhanced anti-tumor activity of PmelAg+IL-12 might be due to their decreased sensitivity to IFN-γ-induced apoptosis. Thus inhibiting IFN-γ-induced activation induced cell death (AICD) by down-regulating IFN-γR2 expression on T cells may represent a novel mechanism by which IL-12 enhances anti-tumor activity.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.